Register för nya läkemedel i cancervården ger värdefull hjälp: Visar en bra bild av hur läkemedlen används - Patienten kan följas i den kliniska vardagen : [Register for new drugs in cancer care provides a picture of how the drugs are used in the daily clinical practice]

• Today, an increasing number of cancer drugs are approved before traditional well-controlled phase 3 studies have been conducted and in many registration studies there is no participation of Swedish departments. This article describes the general experience of a caregiver initiated systematic followup of new cancer drugs that shows the possibility of obtaining a picture of the drug’s use in routine care. From the register “New Pharmaceuticals in Cancer care”, registrations from Stockholm-Gotland region are reported. The structure of the registry can be used with advantage in other therapeutic areas than cancer and can be supplemented with data from national and regional registers as well as quality registers including patient experiences. The knowledge is important to many actors in health care and can contribute to an evidence based, patient-safe and equal healthcare in accordance with current guidelines.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Publication and Content Type

ref (subject category)

art (subject category)